Instalab

Urine Protein-to-Creatinine Ratio

Urine Test
A simple signal that your kidneys may be quietly leaking, often years before standard blood work catches it.

Should you take a UPCR test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Catch silent kidney leakage years before standard blood work shifts, especially if you want a head start on prevention.
Living with Diabetes or Prediabetes
See whether high blood sugar is starting to damage your kidneys, even if your eGFR still looks normal.
Managing High Blood Pressure
Find out whether your blood pressure is quietly straining your kidney filters, before you notice symptoms.
Family History of Kidney Disease
Get an early read on whether your kidneys are leaking protein, especially if a parent or sibling has had kidney trouble.

About Urine Protein-to-Creatinine Ratio

Healthy kidneys keep almost all protein inside your bloodstream. When the filtering units start to fail, protein begins slipping into your urine, usually long before symptoms appear and often before your blood creatinine moves. UPCR (urine protein-to-creatinine ratio) is the quickest way to catch that leak.

Instead of collecting urine for 24 hours, this test uses a single sample and corrects for how concentrated your urine is by dividing protein by creatinine. The result approximates your daily protein loss, and elevated values predict kidney decline, heart disease, and earlier death across many populations.

What This Test Actually Measures

Two things are measured in your urine. The first is total protein, a mixed pool of albumin plus other proteins that have escaped through the kidney's filter or were not reabsorbed by the tubules. The second is creatinine, a waste product from muscle that your kidneys excrete at a fairly steady rate throughout the day.

By dividing one by the other, the test cancels out the effect of how much water you drank or how concentrated your urine happens to be. The number you get back, usually expressed as milligrams of protein per gram of creatinine (mg/g) or milligrams per milligram (mg/mg), reflects the rate of protein loss your kidneys are running at.

Why Protein in Urine Matters

The kidney's filter is built to keep large molecules like proteins inside the bloodstream while letting waste through. When that barrier is damaged by high blood pressure, diabetes, autoimmune attack, or aging, protein begins to leak. The amount that leaks tracks closely with how much damage has occurred and how fast the kidney is losing function.

This leak is not just a kidney issue. Protein in the urine is one of the strongest independent predictors of cardiovascular events and death, even when blood pressure and cholesterol look acceptable. The vessels in your kidneys are a window onto the vessels in the rest of your body.

Kidney Disease Progression

Higher UPCR is linked in a stepwise way to faster loss of kidney function and higher risk of progressing to kidney failure. Across many chronic kidney conditions, including diabetic, hypertensive, and inherited types, the level of protein loss tracks how aggressively the disease is moving.

Risk is not flat across the sub-nephrotic range. In one cohort of people with chronic kidney disease, UPCR values below 500 mg/g were not clearly associated with higher progression risk over about three years. Excess risk only appeared at roughly 700 to 1,000 mg/g, where the chance of progression was several times higher than the lowest group. Above 3.5 mg/mg (3,500 mg/g), protein loss is in the nephrotic range and indicates serious kidney injury.

Heart Disease and Death

Protein loss in the urine is one of the most powerful kidney-related predictors of cardiovascular disease and all-cause mortality. The link holds up even when standard kidney filtration looks normal, meaning UPCR can flag risk before your eGFR (estimated glomerular filtration rate, a measure of how well your kidneys clean blood) starts to slip.

In a study of 2,904 adults, looking at urine protein loss alongside the albumin fraction (UACR, urine albumin-to-creatinine ratio) gave a more accurate read on mortality risk than either measurement alone. People with heavy proteinuria can carry double or higher mortality risk compared with those whose urine is clean, even when the rest of their workup looks fine.

Type 2 Diabetes

In type 2 diabetes, the part of UPCR that is not albumin (called non-albumin protein) carries unique prognostic weight. In a retrospective study of 1,809 adults with type 2 diabetes, a non-albumin protein-to-creatinine ratio above 120 mg/g was an independent predictor of dying from any cause, sometimes a stronger signal than albumin loss alone.

This is why ordering UPCR alongside the more common albumin-to-creatinine ratio gives you information about kidney injury that pure albumin testing can miss, particularly tubular damage where smaller proteins leak through that albumin testing does not capture.

Pregnancy and Preeclampsia

In pregnancy, sudden protein loss is a hallmark of preeclampsia, a serious blood-pressure complication. The International Society for the Study of Hypertension in Pregnancy uses a UPCR cutoff of 30 mg/mmol (about 0.3 mg/mg) to flag significant proteinuria. Spot ratios at this threshold catch significant proteinuria with about 90 percent sensitivity and specificity compared with timed collections.

Reference Ranges

These ranges come from clinical guidelines and a study of 1,321 healthy adults in Dalian, China, where the upper-limit reference for the cohort was 141.7 mg/g (128.7 mg/g for men, 150.8 mg/g for women) using morning spot urine. Women tend to have higher values than men at the same age. Lab assays for protein and creatinine vary, so use these as orientation, not absolutes. Your lab may report results in mg/mg or mg/mmol; multiply mg/mg by about 113 to get mg/mmol.

TierRange (mg/g creatinine)What It Suggests
NormalUnder 150Protein loss within typical healthy adult range
Mildly elevated150 to 300Borderline; worth retesting and investigating risk factors
Significant proteinuriaAbove 200 to 300Pathologic protein loss; kidney injury likely
Heavy / nephrotic rangeAbove 3,500 (3.5 mg/mg)Severe kidney injury; needs prompt nephrology workup

Compare your results within the same lab over time for the most meaningful trend, since assay differences can shift the absolute number across labs.

Tracking Your Trend

A single UPCR can swing more than you would expect. In adults with chronic kidney disease, day-to-day variability is large enough that for a low baseline value (around 0.2 g/g), a change has to exceed about plus or minus 160 percent to be 95 percent likely to be a real shift. For a higher baseline (around 1.8 g/g), the threshold is about plus or minus 50 percent. In diabetes, the related albumin-to-creatinine ratio shows a within-person coefficient of variation around 49 percent, meaning a repeat reading can land anywhere from roughly a quarter to nearly four times the first one purely by chance.

This is why a single number rarely tells the full story. Get a baseline, repeat in 3 to 6 months if you are making changes or starting a medication, and at least annually after that. When a result will drive a real decision, get two or three samples, ideally at the same time of day, and use the average. Morning samples tend to be the most consistent.

What To Do With An Abnormal Result

A high UPCR on its own is a signal, not a diagnosis. The next step is to confirm with a repeat test, ideally a first-morning sample, and to order companion tests that fill in the picture: an albumin-to-creatinine ratio (UACR) to separate albumin from non-albumin protein, eGFR with cystatin C for a more accurate filtration measurement, and a urinalysis with microscopy to check for blood, casts, or infection.

If the elevation is confirmed, the workup expands depending on context. Persistent proteinuria with diabetes or hypertension warrants intensified blood pressure and glucose control plus a discussion of kidney-protective drug classes. Heavy or nephrotic-range protein loss, or a sudden rise without obvious cause, is a reason to involve a nephrologist promptly. Patterns that combine high UPCR with low eGFR, blood in the urine, or a strong family history of kidney disease almost always benefit from specialist input.

When Results Can Be Misleading

  • Very dilute or very concentrated urine: in a study of 540 adults, dilute urine (creatinine under about 39 mg/dL) tended to overestimate daily protein loss, while concentrated urine (creatinine above about 62 mg/dL) tended to underestimate it. This can misclassify your kidney status from a single sample.
  • Acute kidney injury: clinicians used to discard UPCR during acute kidney injury because of unstable creatinine, but a study of 329 adults found ratios stayed informative regardless of whether serum creatinine was rising or falling.
  • Drugs that lower the number without reflecting cure: SGLT2 inhibitors, mineralocorticoid receptor antagonists like finerenone, statins, and ACE inhibitors all lower urine protein as part of their action. The drop is real and protective, but it represents pharmacology, not the disappearance of the underlying condition. Bardoxolone methyl can raise the ratio while filtration improves, the opposite of an injury pattern.
  • Low muscle mass or low protein intake: creatinine is generated from muscle, so very low muscle mass or strict low-protein diets lower the denominator and inflate the ratio. Strenuous exercise just before sampling can also bump creatinine.

For high-stakes decisions like changing immunosuppression in lupus nephritis or interpreting borderline results in the 500 to 1,000 mg/day range, a 24-hour collection is still the more reliable confirmation.

What Moves This Biomarker

Evidence-backed interventions that affect your UPCR level

Decrease
ACE inhibitors and angiotensin receptor blockers (ramipril, lisinopril, losartan, etc.)
These blood-pressure drugs are first-line therapy for proteinuric kidney disease and reduce urine protein loss while protecting filtration over time. In hypertensive patients, ramipril produced slower GFR decline than amlodipine at similar levels of protein excretion, and proteinuria response on these drugs is one of the strongest predictors of long-term kidney protection.
MedicationStrong Evidence
Decrease
SGLT2 inhibitors (empagliflozin, dapagliflozin)
Lower albuminuria by roughly 25 to 40 percent, with larger drops in those with higher baseline protein loss. In the DAPA-CKD trial of 4,304 adults with chronic kidney disease, dapagliflozin significantly reduced the risk of sustained kidney function decline, end-stage kidney disease, or death from kidney or cardiovascular causes.
MedicationStrong Evidence
Decrease
Mineralocorticoid receptor antagonists (spironolactone, eplerenone, finerenone)
Reduce urine protein-to-creatinine ratio by about 54 percent and albumin-to-creatinine ratio by about 25 percent in meta-analyses, alone or added to ACE inhibitors or ARBs. In the CONFIDENCE trial, combining finerenone with empagliflozin cut UACR by about 50 to 56 percent versus baseline.
MedicationStrong Evidence
Decrease
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide)
In a real-world study of 253 obese adults with type 2 diabetes on metformin, adding a GLP-1 agonist lowered urine albumin-to-creatinine ratio and improved eGFR over 24 months. Effects on UACR are seen alone or stacked on top of SGLT2 inhibitors.
MedicationModerate Evidence
Decrease
Statins (atorvastatin and others)
In a controlled study of 56 adults with chronic kidney disease, hypercholesterolemia, and proteinuria, atorvastatin added to ACE inhibitor or ARB therapy reduced 24-hour protein excretion from 2.2 to 1.2 grams while controls saw little change. A meta-analysis confirmed statins reduce microalbuminuria and proteinuria in non-end-stage kidney disease.
MedicationModerate Evidence
Decrease
Low-protein or plant-dominant low-protein diet
In a meta-analysis of randomized controlled trials in diabetic nephropathy, a low-protein diet decreased urinary albumin excretion rate and proteinuria. A plant-dominant low-protein approach may slow chronic kidney disease progression by reducing the filtering load on the kidneys.
DietModerate Evidence
Decrease
Weight loss in adults with obesity
A systematic review of clinical trials and comparative cohorts found weight loss through dietary restriction, exercise, or bariatric surgery was associated with decreased proteinuria and microalbuminuria in adults with obesity. Reducing kidney filtration overload appears to translate into less protein leak.
LifestyleModerate Evidence
Decrease
Structured exercise training in chronic kidney disease
A meta-analysis of exercise training in adults with chronic kidney disease found that exercise did not aggravate proteinuria and may modestly reduce it. In obese diabetic adults with chronic kidney disease, structured exercise improved exercise capacity without worsening kidney function.
ExerciseModest Evidence

Frequently Asked Questions

References

27 studies
  1. Kamińska J, Dymicka-piekarska V, Tomaszewska J, Matowicka-karna J, Koper-lenkiewicz OCritical Reviews in Clinical Laboratory Sciences2020
  2. Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew S, Coresh J, Matsushita K, Heerspink HJLAnnals of Internal Medicine2020
  3. Liu T, Xue B, Du B, Cui T, Gao X, Wang Y, Wei JLJournal of Clinical Laboratory Analysis2021